全球心血管器材市场规模、份额、趋势和成长分析报告（2026-2034）

预计心血管器材市场将从 2025 年的 752.8 亿美元成长到 2034 年的 1,518.6 亿美元，2026 年至 2034 年的复合年增长率为 8.11%。

由于全球心血管疾病盛行率不断上升以及医疗费用支出持续成长，全球心血管器材市场正经历强劲成长。支架、心律调节器和诊断设备等心血管器械对于治疗冠状动脉疾病、心律不整和其他心臟疾病至关重要。人口老化和久坐的生活方式也显着推动了市场需求。

关键成长要素包括微创手术和植入式医疗器材的技术进步。导管介入治疗方法的普及和影像技术的改进正在提升治疗效果。此外，人们对预防性心臟护理和早期诊断意识的提高，也促进了医疗器材在整个医疗保健系统中的广泛应用。

展望未来，生物可吸收支架、穿戴式心臟监测设备和人工智慧辅助诊断技术等创新可望推动市场发展。新兴国家医疗基础设施的扩建将带来新的成长机会。持续进行旨在提升设备安全性和耐用性的研发工作，将继续有力地支持全球市场的扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球心血管器材市场：依器材类型划分

• 市场分析、洞察与预测
• 诊断和监测设备
• 治疗及外科器械

第五章 全球心血管器材市场：依应用划分

• 市场分析、洞察与预测
• 冠状动脉疾病（CAD）
• 心律不整
• 心臟衰竭
• 其他的

第六章 全球心血管器材市场：依最终用户划分

• 市场分析、洞察与预测
• 医院
• 专科诊所
• 其他的

第七章 全球心血管器材市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • B. Braun Melsungen AG
  • Medtronic
  • Abbott
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services Inc
  • General Electric Company（GE Healthcare）
  • LivaNova PLC
  • Siemens Healthcare GmbH
  • Terumo Cardiovascular Systems Corporation

The Cardiovascular Devices Market size is expected to reach USD 151.86 Billion in 2034 from USD 75.28 Billion (2025) growing at a CAGR of 8.11% during 2026-2034.

The Global Cardiovascular Devices Market is experiencing robust growth due to rising prevalence of heart diseases and increasing healthcare expenditure worldwide. Cardiovascular devices, including stents, pacemakers, and diagnostic equipment, are essential in managing coronary artery disease, arrhythmias, and other heart conditions. Growing aging populations and sedentary lifestyles are contributing significantly to market demand.

Key growth drivers include technological advancements in minimally invasive procedures and implantable devices. Expansion of catheter-based interventions and improved imaging technologies are enhancing treatment outcomes. Additionally, growing awareness about preventive cardiac care and early diagnosis is supporting increased device utilization across healthcare systems.

Looking ahead, the market is expected to benefit from innovation in bioresorbable stents, wearable cardiac monitoring devices, and AI-assisted diagnostics. Expanding healthcare infrastructure in emerging economies will provide new growth avenues. Continuous research and development efforts aimed at improving device safety and longevity will likely sustain strong global market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Device Type

• Diagnostic and Monitoring Devices
• Therapeutic and Surgical Devices

By Application

• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

By End User

• Hospitals
• Specialty Clinics
• Others

COMPANIES PROFILED

• B Braun Melsungen AG, Medtronic, Abbott, Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson Johnson Services Inc, General Electric Company GE Healthcare, LivaNova PLC, Siemens Healthcare GmbH, Terumo Cardiovascular Systems Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY DEVICE TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Device Type
• 4.2. Diagnostic and Monitoring Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutic and Surgical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Coronary Artery Disease (CAD) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac Arrhythmia Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIOVASCULAR DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Device Type
  • 7.2.2 By Application
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Device Type
  • 7.3.2 By Application
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Device Type
  • 7.4.2 By Application
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Device Type
  • 7.5.2 By Application
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Device Type
  • 7.6.2 By Application
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIOVASCULAR DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 B. Braun Melsungen AG
  • 9.2.2 Medtronic
  • 9.2.3 Abbott
  • 9.2.4 Boston Scientific Corporation
  • 9.2.5 Edwards Lifesciences Corporation
  • 9.2.6 Johnson & Johnson Services Inc
  • 9.2.7 General Electric Company (GE Healthcare)
  • 9.2.8 LivaNova PLC
  • 9.2.9 Siemens Healthcare GmbH
  • 9.2.10 Terumo Cardiovascular Systems Corporation